# Commission Implementing Regulation (EU) No 418/2014 of 24 April 2014 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance ivermectin (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ivermectin is replaced by the following:
Pharmacologically active substance
Marker residue
Animal species
MRL
Target tissues
Other provisions (according to Article 14(7) of Regulation (EC) No 470/2009)
Therapeutic classification
‘Ivermectin
22, 23-Dihydro-avermectin B 1a
All mammalian food producing species
30 μg/kg
100 μg/kg
100 μg/kg
30 μg/kg
Muscle
Fat
Liver
Kidney
For porcine species the fat MRL relates to “skin and fat in natural proportions”
Not for use in animals from which milk is produced for human consumption
Antiparasitic agents/Agents acting against endo and ectoparasites’

---
Source: https://www.legislation.gov.uk/eur/2014/418/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2014-418/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.